RxDoctor Payments Data
★ My doctorsLook up a doctor →

Nicole Smith

Family · Neptune, NJNPI 1013590876

Payments from drug & device makers

$3,801in general payments, 2019–2025

Across 229 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$813
  • Neurelis, Inc.$346
  • SK Life Science, Inc.$315
  • Teva Pharmaceuticals USA, Inc.$307
  • Servier Pharmaceuticals LLC$156
  • AbbVie$151
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$3,801100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.55$813
Neurelis, Inc.24$346
SK Life Science, Inc.13$315
Teva Pharmaceuticals USA, Inc.20$307
Servier Pharmaceuticals LLC9$156
AbbVie10$151
Tanabe Pharma America, Inc.8$131
Argenx US, Inc.7$116
Amgen8$113
Lilly USA, LLC7$110
Lundbeck LLC5$88
TG Therapeutics, Inc.1$88
Baxter Healthcare1$87
Aquestive Therapeutics, Inc.6$84
Tonix Medicines, Inc.5$77
Amneal Pharmaceuticals LLC4$72
Convatec Inc.3$68
Jazz Pharmaceuticals Inc.4$67
Smith+Nephew4$56
Neurocrine Biosciences, Inc.3$54
AstraZeneca(2 entities)3$46
Aprecia Pharmaceuticals, LLC3$43
Almatica Pharma LLC3$41
KCI USA, Inc.2$37
Biogen2$37
Novocure Inc.2$37
Eisai Inc.2$31
Aucta Pharmaceuticals, Inc.2$31
Biohaven Pharmaceutical Holding Company Ltd.2$29
Pfizer1$19
Merz Pharmaceuticals, LLC1$18
Electromed, Inc.1$18
Kyowa Kirin, Inc.1$17
W. L. Gore & Associates, Inc.1$15
Siemens Medical Solutions USA, Inc.1$15
OWP Pharmaceuticals, Inc.1$15
Springworks Therapeutics, Inc.1$14
Impel Pharmaceuticals Inc.1$13
Biohaven Pharmaceuticals, Inc.1$13
Biocodex, Inc.1$12

How this compares

$3,801 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Medicare billing

Part B allowed, 2024
$4,101
Medicare patients
11
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Neptune

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →